MONG patients who harbor mass lesions that reside near or within functional cortex, the task of deciding which masses may be safely resected and which surgical approach to use remains a severe test of resourcefulness for even the most seasoned neurosurgeon. Empirical methods based on surface anatomical landmarks obtained from computerized tomography and MR images have traditionally been used by neuroradiologists to identify functional brain structures. 3, 17, 21, 27, [31] [32] [33] [34] [35] However, individual variability in brain structure and physiology and the alteration in these variations by pathological masses often render empirical methods inaccurate. Recently, Sobel, et al., 42 tested the reproducibility of a neuroradiological method to assess the location of functional cortex by comparing the extent to which two neuroradiologists agreed on the identification, based on MR images, of the central sulcus. Among the 127 MR imaging sections examined, they found that the radiologists disagreed by at least one sulcus more than 20% of the time.
MONG patients who harbor mass lesions that reside near or within functional cortex, the task of deciding which masses may be safely resected and which surgical approach to use remains a severe test of resourcefulness for even the most seasoned neurosurgeon. Empirical methods based on surface anatomical landmarks obtained from computerized tomography and MR images have traditionally been used by neuroradiologists to identify functional brain structures. 3, 17, 21, 27, [31] [32] [33] [34] [35] However, individual variability in brain structure and physiology and the alteration in these variations by pathological masses often render empirical methods inaccurate. Recently, Sobel, et al., 42 tested the reproducibility of a neuroradiological method to assess the location of functional cortex by comparing the extent to which two neuroradiologists agreed on the identification, based on MR images, of the central sulcus. Among the 127 MR imaging sections examined, they found that the radiologists disagreed by at least one sulcus more than 20% of the time.
Of course, sophisticated methods of functional localization are widely available. The standard neurodiagnostic modality for the assessment of functional organization during intracranial surgery is ECoG monitoring. 4, 6, 9, 14, 30, 40 The advantage of ECoG monitoring is that it allows precise intraoperative identification of functional cortex, which in turn allows neurosurgeons to avoid inadvertent damage to these functionally important areas.
The advent of clinical MEG 7, 8, 45 and the merging of the technologies of MEG and MR imaging have resulted in the development of a relatively new technology, MS imaging. 12, [22] [23] [24] 38, 39 Like ECoG recording, MS imaging provides information on the location of functional cortex. One of the advantages of MS imaging over ECoG studies is that it generates this information by noninvasive means. Magnetic source imaging provides an image that facilitates the preoperative decision-making process and also serves as an intraoperative road map. Moreover, MS imaging demonstrates not only the location of functional cortex but also its topographic relationship to the intracranial mass.
Although further studies are necessary to assess the accuracy of MS imaging, preliminary studies of its accuracy in comparison with ECoG studies and other methods of functional localization have corroborated its precision as a method of functional cortical mapping. [10] [11] [12] [13] 28, 29, 39, 43, 44 Despite interest shown in the more technical aspects of MS imaging, 10, 15, 19 its clinical utility has been assessed in relatively few studies. 11, 13, 16, 25, 28, 29, 39 We set this as our goal and, thus, have reviewed MS imaging results, the impact of MS imaging on the clinical decision-making process, and surgical outcome data in those patients who have undergone surgery following a preoperative evaluation with MS imaging. We present these results to assess the role of MS imaging in the clinical decision-making process and the intraoperative care of patients with intracranial masses located near or within functional cortex.
Clinical Material and Methods

Demographics and MS Imaging Protocol
All consecutive patients with an intracranial mass located near or within functional cortex who underwent evaluation with MS imaging at the New Mexico Regional Federal Medical Center between May 1995 and January 1997 were included in this study. There were 18 male and eight female patients whose age ranged from 11 to 75 years (mean 55.3 years) ( Table 1) . Participating surgery centers included: New Mexico Regional Federal Medical Center, University of New Mexico Health Sciences Center, and Lovelace Medical Center. Each patient was initially evaluated by formal neurological examination and assignment of a preoperative KPS score (Table 1) . 18 Each patient was also assigned to an MS imaging protocol that included somatosensory cortex mapping, with or without visual cortex and auditory cortex mapping, depending on the location of the intracranial lesion.
The studies were performed in a magnetically shielded room with a commercially available 122-channel wholehead biomagnetometer (Neuromag-122 whole-head biomagnetometer; Neuromag, Helsinki, Finland) (Fig. 1) . The positioning of the patient in the biomagnetometer was determined by measuring the position of fiducial markers and small magnetic coils on the patient's head. Standard fiducial points included the left and right tragi and the nasion.
For the somatosensory mapping protocol, the median and tibial nerves, both contralateral and ipsilateral to the side of the lesion, were stimulated at the wrist and ankles with constant-current 200-sec pulses at a current that did not exceed 15 mA. The visual mapping protocol used target stimuli presented in the right and left upper and lower visual quadrants in the near and far periphery. This protocol is designed to test the location of the primary visual cortex. Auditory studies were conducted by the presentation of pure tones, both binaurally and monaurally. For median nerve measurements the filter was set at 10 to 150 Hz; for tibial nerve measurements the filter was set at 5 to 50 Hz. The number of averages per trial was 100. Latency duration for the median nerve was 15 to 30 nsec and that for the tibial nerve was 30 to 50 nsec.
Imaging was performed in each patient by using a 1.5-tesla MR imaging system (Picker Edge, Cleveland, OH), with 2-mm-diameter markers to indicate fiducial and magnetic coil locations. Locations of the fiducial markers used for acquisition of both MEG and MR imaging were selected for transformation of MEG locations into the MR coordinate frame, resulting in coregistration of MEG and MR imaging data sets. The functional dipole source was calculated mathematically from a map of the magnetic field measured by the MEG sensors. This corresponded to the location of those neurons contributing to the recorded magnetic signal. This was represented as a dot in three-dimensional space, which was then projected onto the coregistered MR imaging data set.
The dimensions of the intracranial mass in each case were measured, and the distance between the intracranial mass and functional cortex was determined. This distance was measured from the best-fitting functional dipole (as determined by MEG) to the closest edge of the intracranial lesion. After localization of the dipole on the ipsilateral side, the dipole was compared with its counterpart on the opposite side to determine whether it was displaced by the lesion.
Surgical Technique and Outcome
A Cosman-Roberts-Wells frame (Radionics, Inc., Burlington, MA) was used in all stereotactic biopsy procedures. With each open surgical procedure, a frameless stereotactic navigational system (Viewpoint; Picker) was used as a surgical adjunct in conjunction with the preoperative MS imaging data. To incorporate functional information onto frameless stereotactic images, the functional dipoles obtained by the MS imaging examination were mapped onto the images to be used intraoperatively with the frameless stereotaxy.
Surgical outcome was assessed by neurological examination, along with the patient's best functional level within 2 weeks of operation. This functional level was recorded according to the patient's KPS score, and the difference between the preoperative and postoperative KPS scores was noted. Pathological diagnosis and neurological complications were also noted.
Results
Results of MS Imaging
The lesions included 15 right-hemisphere masses and 11 left-hemisphere masses ( Table 2 ). The most common mass location was the frontal lobe (10 patients). The temporal, parietal, and parietooccipital areas each were involved in three patients. Lesion size ranged from 1.5 to 5.5 cm (mean 3.3 cm). In 19 patients, the MS imaging protocol consisted of an evaluation of the somatosensory cortex only. It is noteworthy that 10 of the 11 patients with hemiparesis had successful MS imaging localization of the somatosensory cortex. In three patients, the MS imaging evaluation involved the somatosensory and visual cortices; in three patients the somatosensory, visual, and auditory cortices; and in one patient, the auditory cortex alone.
The location of functional cortex was normal in all but three patients. In two cases, the somatosensory cortex was displaced posteriorly. In one case, the auditory cortex was displaced posteriorly. For all patients, the location of the lesion in relation to functional cortex is presented in Table  3 . The distance between the lesion and functional cortex was measured from the nearest function mapped to the edge of the intracranial lesion. These distances ranged from 0 to 40 mm (mean 16.2 mm).
Results of Surgery
Five patients did not undergo surgery ( Table 4) . One of these patients (Case 6) had deteriorated neurologically and, therefore, was not a candidate for surgery. Two patients (Cases 11 and 12) were offered surgery but declined. Two other patients (Cases 2 and 3) were not offered surgery because their MS imaging evaluations had indicated that the lesion was located within functional cortex; one of these patients (Case 3) had undergone a previous stereotactic biopsy.
Twenty-one patients underwent an operation ( navigational system was used as a surgical adjunct in these 17 patients. For those patients who underwent a surgical procedure, the approach was chosen based on the location of the lesion in relation to functional cortex, as indicated in Table 3 .
Patient Outcome and Pathological Diagnosis
The patients' preoperative KPS scores ranged from 40 to 90 (mean 76.5), and their postoperative KPS scores ranged from 40 to 90 (mean 75.4) ( Table 5 ). The postoperative KPS score was unchanged from the preoperative scores in 15 of the 21 patients who underwent surgery. Among those whose score changed, the KPS score in three patients improved and that in three patients worsened. The results of the postoperative neurological examination and the final pathological diagnosis in each patient are listed in Table 5 . The breakdown for diagnoses was as follows: glioblastoma multiforme in seven patients, metastatic lesion in five, oligodendroglioma in three, meningioma in three, Grade III astrocytoma in two, glioma in one, ganglioglioma in one, and hemangiopericytoma in one.
There was no correlation among lesion size, tumor grade, and functional outcome. An analysis of the relationship between the distance from the lesion to functional cortex and the functional outcome was limited by technical difficulties associated with motor cortex mapping. Although the motor cortex could be identified in 100% of cases, no modeled dipole was derived for motor function (because of its technical difficulty, see Discussion) and, thus, no precise measurement could be computed for the distance between the lesion and the motor cortex.
Surgery-Related Complications
There were three surgery-related complications ( Table  4 ). The first patient (Case 14) had a normal preoperative neurological examination but developed a severe postoperative hemiparesis after undergoing a subtotal resection of an oligodendroglioma (50-point change in KPS score; see Case 14 in the following section). The second patient (Case 21) experienced a worsened monoparesis after undergoing a subtotal resection of a glioblastoma multiforme (10-point change in KPS score). The third patient (Case 23) experienced a worsened hemiparesis after undergoing a stereotactic biopsy for a thalamic metastatic lesion (10-point change in KPS score). 
Illustrative Cases
Case 5
This case illustrates how the precise localization of functional cortex by MS imaging may be used intraoperatively to avoid injury to the somatosensory and motor cortices by helping select the safest surgical trajectory. This 44-year-old man presented with a KPS score of 70 and a mild left-sided hemiparesis. The offending 4-cm mass was located within the right primary motor cortex (Fig. 2) . A frameless stereotactic navigational system provided the surgeons with information regarding the location of the operative site in relation to the tumor and functional cortex. This information allowed the surgeons to plan for a frontal rather than a posterior approach to the tumor and to avoid direct injury to the MS imaging-identified rolandic cortex. The patient underwent a right frontoparietal craniotomy and a subtotal resection of tumor. Simply resecting the tumor within its enhancing borders may not preclude the potential of injuring the patient because functional tissue may be preserved within the tumor. 37, 41 The preoperative hemiparesis improved immediately postoperatively, and the patient's KPS score increased by 10 points. The pathological diagnosis was glioblastoma multiforme.
Case 4
This case also illustrates the use of MS imaging for the selection of a surgical approach that avoids iatrogenic injury to functional cortex. This 63-year-old man presented with a left-sided homonymous hemianopsia and a KPS score of 90. Magnetic source imaging localized the visual cortex to 5 mm inferior to the 4-cm mass (Fig. 3) . Although the MS imaging appearance was suggestive of meningioma preoperatively, there was some concern about whether the mass might have been an intraaxial tumor, particularly given the cystic component. Preoperative localization of the primary visual cortex at the inferior, rather than superior, margin of the mass dictated a parietooccipital approach rather than an inferior occipital one. The surgeon's confidence was further enhanced by the use of frameless stereotaxy as a surgical adjunct. Postoperatively, the patient's neurological deficit and KPS score were unchanged. The pathological diagnosis was meningioma.
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Case 3
This case demonstrates how information provided by MS imaging may tip the balance in favor of no surgery. This 46-year-old woman presented with a right lower-extremity monoparesis, gait ataxia, and a KPS score of 90.
Evaluation by MS imaging revealed that a portion of the tumor was located in the primary motor cortex (Fig. 4) . According to a previous biopsy, which had been performed at another institution, the pathological diagnosis was oligodendroglioma. Given that the patient's mild neurological deficit was nonprogressive and the tumor was located partially in the primary motor cortex, the patient was not offered surgery. Instead, she was referred for radiation therapy.
Case 14
This case demonstrates the danger associated with not using MS imaging functional data when resecting a mass that is located near functional cortex. This 43-year-old woman presented with a single generalized seizure. Magnetic resonance imaging revealed a 4-cm lesion in the upper right parietal area, 11 mm inferior to the primary sensorimotor cortex, as determined by the tibial nerve MS imaging response (Fig. 5 left) . Based on findings on MR imaging, the patient was selected for an interhemispheric approach, and a subtotal resection was planned. Although an MS imaging examination was obtained preoperatively, the MS imaging data were not used by the surgeon. Instead, the surgeon preferred to use the more familiar method of obtaining intraoperative somatosensory evoked potentials to identify the location of functional cortex. As a result of technical difficulties in the process of cortical mapping, however, the surgeon was forced to abandon ECoG monitoring and to rely instead on surface anatomical landmarks. Despite the fact that meticulous attention was paid to these landmarks, the location of the motor cortex was nevertheless misidentified and, therefore, violated via the trajectory of the surgery (Fig. 5 right) . As a result, the patient sustained a severe postoperative neurological deficit. Her KPS score changed from 90 preoperatively to 40 after onset of the new deficit. The pathological diagnosis was low-grade oligodendroglioma. 
Case 17
This case again illustrates how precise identification of the central sulcus can be useful in selecting a minimumrisk stereotactic trajectory. This 55-year-old man presented with a mild left-sided hemiparesis and a KPS score of 70. Magnetic source imaging identified the displacement of right somatosensory cortex by a 4-cm mass (Fig. 6) . Because MS imaging data indicated that the tumor was located anterior to the sensorimotor cortex, an anterior stereotactic biopsy trajectory was selected. Postoperatively, both the neurological examination and the KPS score were unchanged. The pathological diagnosis was Grade III astrocytoma. The patient was referred for radiation therapy.
Case 26
This case demonstrates the use of MS imaging in the selection of stereotactic biopsy over craniotomy, as well as the choice of the optimal stereotactic trajectory. This 75-year-old man presented with a mild left-sided hemiparesis and a KPS score of 70. Magnetic source imaging documented a 3-cm mass located within the right primary motor cortex, which extended posterior to the central sulcus (Fig. 7) . A stereotactic biopsy was performed via a right posterior parietal approach, thus avoiding the MS imaging-identified motor and somatosensory cortices. Postoperatively, the neurological examination and the KPS score were unchanged. The pathological diagnosis was glioblastoma multiforme.
Discussion
Development of MEG Studies
With the advent of MEG studies in the late 1960s, it became possible to detect extremely low magnetic fields produced by ␣-rhythm currents in the brain. 8 Brain activity is associated with the emission of magnetic signals of a few picoteslas. For the sake of comparison, this is six orders of magnitude smaller than the transient environmental magnetic fields produced by power lines and electrical machinery, eight orders of magnitude smaller than the earth's steady magnetic field, and 12 orders of magnitude smaller than the magnetic field associated with MR imagers.
However, with the development of a superconducting quantum interference device, scientists and clinicians possessed the ability to detect extremely low amplitude neuromagnetic signals and to distinguish them from surrounding environmental magnetic noise. The instrument used in the clinical application of this technology is a biomagnetometer, which operates at temperatures close to absolute zero, a condition that induces superconductive properties in low-impedance wires. To reduce external noise, the biomagnetometer is operated in a magnetically shielded room.
Advantages of MEG Studies
Unlike EEG-based techniques, which measure electrical potentials that are the result of extracellular volume currents, the magnetic fields measured with MEG primarily reflect intracellular current flow. The advantages of MEG over EEG studies for functional brain mapping are several fold. Compared with EEG monitoring, MEG studies provide excellent spatial and temporal resolution for localization of cortical (especially fissural) neural activity. This is explained in part by the attenuations of EEG-related electrical potentials, which occur across the inhomogeneously conducting layers of scalp, skull, and extracerebral tissues. Because the magnetic fields produced by neuronal currents are not attenuated by inhomogeneously conducting intervening layers, MEG studies are not affected by the multiple tissue layers between the brain and the external surface of the head. Furthermore, the signal detected by EEG monitoring is significantly distorted by mass lesions or other pathological changes in the brain, which do not affect the signal detected by MEG studies.
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Magnetic source imaging As a result, in the presence of pathological changes, the localization of functional cortex is more accurately represented by MEG than EEG studies. As an example, standard scalp EEG monitoring cannot directly localize the motor cortex, whereas MEG has been described to be relatively accurate. [10] [11] [12] [13] 28, 29, 38, 43, 44 The right-hand rule of physics states that the flux lines of a magnetic field associated with an electrical current are oriented at 90˚ in relation to the direction of current flow and encircle the current in a right-handed direction (Fig. 8 left) . It follows from this that MEG can most easily detect the magnetic flux produced by activation of neurons that are oriented tangential to the skull. The magnetic flux associated with neurons that are oriented perpendicular to the skull is not detected by MEG studies, because it is directed parallel to the surface of the head and because the flux lines that are associated with volume flow cancel one another out (Fig. 8 right) .
The practical consequence of these phenomena is that the signal detected by MEG studies is more sharply defined than the signal detected by EEG studies. The reasons for this are twofold. First, MEG is less subjected to the attenuation effects that distort the signal detected by EEG studies. Second, MEG includes only a tangential component of neuronal current and is, therefore, less complex than the signal detected by EEG studies, which includes both a tangential and a radial component of neuronal current.
Magnetic Source Imaging
A decade ago, the clinical utility of MS imaging was hampered by a relative lack of computer power and the long imaging times required by seven-channel biomagnetometers. The most recent generation of biomagnetometers offers up to 61 recording locations via 122 channels. Such large-array biomagnetometers consist of full-head systems that obviate the need for acquiring multiple data sets. Studies in which these newly available biomagnetometers are used may thus be completed in less than 2 hours, which includes approximately 20 minutes for patient imaging time. In addition, the newer units provide the potential benefits of monitoring the whole head simultaneously, improving detection of secondary functional areas, and enhancing discrimination of multiple cortical sources. Such advantages of the 122-channel biomagnetometer, however, have been gained at the expense of an increased amount of generated data, the analysis of which has become a formidable task. It may be expected that future improvements in automated data analysis will facilitate more efficient data analysis.
By mapping the neurophysiological data acquired by the biomagnetometer onto the neuroanatomical data set acquired by MR imaging, the functional measurements can be given an anatomical reference. Multiple studies have confirmed the accuracy of cortical localization using MS imaging. These studies have shown that MS imaging compares favorably with ECoG studies, which are the gold standard for cortical functional mapping. [10] [11] [12] [13] 28, 29, 39, 43, 44 Indeed, MS imaging potentially provides enhanced accuracy and clinical utility over ECoG monitoring, predominantly because MS imaging includes data points below the surface of the brain, whereas ECoG monitoring reflects only surface recording of brain activity.
Furthermore, MS imaging provides additional advantages over more recently developed techniques such as functional MR imaging, and the more traditional functional imaging technologies such as single-photon emission computerized tomography and positron emission tomography. 24 The first advantage of MS imaging over these alternative techniques is that it provides a direct measure of brain electrophysiology, rather than a measure of brain metabolism and hemodynamics, which are assumed to change in a predictable and uniform manner in response to a lesion or to the neurophysiological activity of interest. This consideration is not trivial because the relationship between brain metabolism and hemodynamics and the neurophysiological activity of neurons is not precisely known. A second advantage of MS imaging is that it generates a real-time record of neurophysiological changes, which occur on the order of milliseconds. By contrast, hemodynamic changes that are captured by techniques such as functional MR imaging, single-photon emission computerized tomography, and positron emission tomography may develop over several seconds, with a true threshold of no less than 500 msec for activation.
On the other hand, it must be understood that MS imaging is associated with several disadvantages. First, an MS imaging unit is priced in the range of $1.5 million and is available at only a handful of sites throughout the world. Second, MS imaging is still a developing technology; thus, the mathematical models that are used for modeling the magnetic sources are still relatively unsophisticated. Third, huge amounts of data are generated by the most recent generation of biomagnetometers, which requires both labor-intensive and time-consuming data analysis. Finally, most MS imaging facilities presently rely on somatosensory mapping to identify the central sulcus and the motor cortex. This is because direct MEG studies of motor function are difficult to execute because they require significant patient cooperation to perform the motor task to be mapped. Furthermore, despite their great clinical relevance, the language areas of the brain have not been successfully mapped by MEG studies.
Clinical Applications of MS Imaging
Most publications dealing with MS imaging have emphasized the physical principles that underlie this technology or have reported a single or a very small number of clinical case reports. 2, 11, 28, 29 In the present report, we review our experience of using MS imaging in the presurgical and intraoperative care of 26 patients who presented with an intracranial mass lesion located near or within functional cortex.
For most patients who harbor neoplasms or other brain mass lesions, a preoperative MR imaging examination, in conjunction with clinical data, provides sufficient information to select or deselect a patient for surgery. This is true whether the central sulcus can be precisely located. In addition, for those patients who are chosen for neurosurgical intervention, the MR imaging examination is usually a sufficient imaging basis on which to select a surgical approach. However, in a subset of patients, the offending lesion is located within or near functional cortex or has produced such a distortion of normal neuroanatomy that it is not possible to localize critical functional areas of cortex precisely or to determine the topography of these areas in relation to the pathological mass lesion.
It is this group of patients for whom MS imaging provides a noninvasive method of functional localization that may be acquired and analyzed preoperatively. This information can help the surgeon assess the risk of a surgical resection, which, in turn, may be used to facilitate patient counseling. If the lesion is deemed inoperable, a stereotactic biopsy may be planned in lieu of an open procedure. Conversely, lesions that appear inoperable by radiographic criteria, because of their apparent proximity to functional cortex, may in fact be resectable when they are shown to be located distant to functional cortex by a more precise method of functional localization.
Such circumstances are illustrated in a case reported by Benzel, et al. 2 Four neuroradiologists were shown a complete MR imaging series obtained in a 35-year-old man with a left parietal neoplasm. Each neuroradiologist independently misidentified the central sulcus as located more posteriorly (in the region of the tumor) than it actually was. When MS imaging revealed that the central sulcus had been displaced far anterior to the neoplasm and that the tumor was reasonably distant from functional cortex, the patient's surgeon, who initially was reluctant to subject the patient to surgery, chose to undertake an operation to resect the tumor. The surgical resection was performed safely and without complication.
Although MS imaging is most commonly used in the presurgical planning stage, MS images may be used intraoperatively, in conjunction with a frameless or standard stereotactic system, to help guide neurosurgical operative technique. The surgical utility of MS imaging is that it may provide the surgeon with feedback about the topographic relationships among the operative site, mass lesion, and functional cortex. Enhanced definition of these relationships is obtained by mapping the functional dipole obtained by MS imaging onto the intraoperative images used with the frameless stereotactic system. Compared with ECoG recording, this information can be obtained without extending the duration of the surgical procedure. Moreover, an enlarged craniotomy is usually required to perform ECoG monitoring, whereas a small craniotomy may be adequate for a tumor resection that is performed when using MS imaging and frameless stereotaxy.
Present Series of Patients
In the present series of patients, two were not offered surgery because of the critical location of their lesion, which was within, or immediately juxtaposed to, the motor cortex. Neither case was selected for a subsequent biopsy procedure because, in one instance, the neuroimaging appearance was consistent with that of a cavernous malformation and, in the other instance, a previous biopsy had been performed. Before the MS imaging study, identification of functional cortex in the latter case (Case 3) was complicated by the mass effect of the lesion, which displaced the sensorimotor cortex posteriorly. When regional anatomy is distorted by the mass effect of a lesion, the preoperative assessment of functional organization is an exemplary indication for MS imaging. Misinterpretation of the location of functional cortex may lead to inappropriate clinical decision making or to inadvertent surgical compromise of critical structures.
As an alternative to nonoperative management, preoperative assessment of functional organization may favor a combination of stereotactic biopsy and radiation therapy. Such was the case for one patient (Case 17) who presented with a 4-cm mass just anterior to the central sulcus. Given the high risk of producing permanent neurological sequelae by undertaking an open procedure, a stereotactic biopsy was performed. This biopsy procedure rendered a Grade III astrocytoma, and the patient was referred for radiation therapy. Although treatment of a malignant glioma with radiation therapy alone is not an optimum regimen, most surgeons would agree that a relatively intact young person with a mass lesion in the rolandic cortex should be treated conservatively, if possible. Optimally, deliberations on the management of this group of patients should be based on the precise preoperative localization of functional cortex.
Case 5 (Fig. 2) presents another scenario in which preoperative MR imaging suggested that an operation posed a significant risk of neurological injury. However, with the aid of functional localization, as documented by MS im-aging, the patient was deemed an appropriate surgical candidate. The selection of a surgical trajectory that minimized the risk to functional cortex was corroborated intraoperatively by the combined use of MS imaging and frameless stereotaxy.
A minimum-risk strategy was also formulated for the patient in Case 26 (Fig. 7) , in whom a posterior parietal stereotactic trajectory was chosen based on MS imaging data, which indicated that the tumor extended posterior to the central sulcus. A misinterpretation of the relationship between the tumor and functional cortex, based on standard anatomical landmarks, may have led to an improper stereotactic trajectory, with the risk of serious neurological compromise (Fig. 9 left) .
In an opposite anatomical situation, one patient (Case 17; Fig. 6 ) presented with a tumor located anterior to the central sulcus, which indicated that the stereotactic trajectory should be anterior. This is the opposite trajectory to what would have been appropriate if the surgeon (incorrectly) identified the tumor location as posterior to the central sulcus, and it is also different from the trajectory based on the most direct route (Fig. 9 right) . Case 14 (Fig. 5) illustrates a counterexample to the line of argument made earlier. This patient underwent a craniotomy for a lesion located just inferior to the primary sensorimotor cortex. In this case, however, the surgeon did not use the functional MS imaging data, and the patient sustained a devastating postoperative neurological deficit. Retrospective review of the MS imaging data reveals that the surgical trajectory chosen was too far anterior (Fig. 5) . The judicious use of MS imaging, combined with a frameless stereotactic navigational system, may have prevented this untoward event by indicating a surgical trajectory that was posterior to the median nerve response and, therefore, distant to the primary motor cortex. Although the surgeon had planned to use ECoG monitoring to identify the rolandic cortex, in this case the noninvasive mapping accomplished by MS imaging indeed provided the necessary information preoperatively.
Complications in the Present Series
In the present series, there were three surgical complications. As noted, in one case MS imaging was not used. In the two patients in whom a complication occurred despite the use of MS imaging, one patient underwent a standard stereotactic biopsy for a thalamic metastatic lesion, which resulted in a worsened hemiparesis (10-point change in KPS score), and one patient underwent a subtotal resection for a glioblastoma multiforme, which resulted in a worsened monoparesis (10-point change in KPS score).
Although the complication rate for stereotactic biopsies reported here (one complication in four cases) is far greater than published averages, 1, 5, 20, 26, 36 the small number of biopsy samples obtained in this series precludes a meaningful interpretation of this complication rate. The single complication for craniotomy in this series, in which 17 craniotomies were performed, is likewise difficult to interpret given the varied characteristics of our patient population and the small number of procedures performed.
Nevertheless, in our hands, these results appear to represent an improvement in patient outcome for similar patients cared for before the routine application of MS imaging. Given the additional advantages of MS imaging, such as increased surgeon confidence and access to a technique that helps to identify surgical candidates and strategies, we conclude that this technology can enhance clinical practice by improving a surgeon's ability to manage this group of patients appropriately.
Conclusions
Numerous reports have documented and described the physical basis and accuracy of functional mapping using MS imaging. A scattered group of case reports has also suggested some of the clinical uses of this technology. The present report illustrates in greater detail, and for a greater number of patients, existing clinical applications of MS imaging. These applications consist of a noninvasive means of preoperative functional cortical mapping, which facilitates clinical decision making in patients with intracranial masses located near or within functional cortex. This combination of functional and structural data also assists the surgeon in the selection of the safest surgical trajectory and the safest surgical resection technique in those patients who are deemed appropriate surgical candidates.
